就药品获取基金会而言，它将针对目前似乎正在从事替代药、仿制药生产和专注研发工作的八大药企分别展开基准运算工作。
For its part, the AFM will calculate its benchmark separately for the eight major pharmaceutical companies that currently appear to be working on replacement drugs, generic producers, and firms focused solely on research and development.